8th Annual Diversity, Inclusion, & Health Equity Symposium
LEADING SYMPOSIUM DISCUSSING EQUITY IN THE HEALTH SECTOR
Chicago, IL, USA
Chicago, IL, USA
The 8th annual Diversity, Inclusion, & Health Equity Symposium is a leading annual, collaborative event focusing on health equity and health disparities in the U.S. The symposium brings together leading healthcare professionals, executives, physicians, patient groups, patients, researchers, academics, clinical trial professionals, and diversity and inclusion advocates to discuss health equity in the life sciences and the health sectors. The symposium focuses on the latest trends, challenges, opportunities in both the marketplace and workplace, with a specific focus on how to best serve an increasingly diverse patient base. We also aim to address the broader health disparity challenges in the U.S., and the symposium equips attendees with the latest insights and ideas. Attendees will learn practical solutions, share perspectives, and meet new industry and marketplace colleagues.
the world’s #1 symposium focusing specifically on the interface of diversity, inclusion, equity, and the health sector
the obstacles to clinical trials and healthcare access for underrepresented patient populations
knowledge regarding why coaching and mentoring are vital to workforce development
on building an organizational culture that attracts the best and brightest people, resulting in a diverse, equitable, and productive workforce
how diversity and inclusion drive innovation and new thinking within organizations
a workplace that embraces and promotes an inclusive environment by leveraging the latest D&I trends and ideas
best practices for recruiting, retaining , and promoting a diverse workforce
and share ideas with many of the country’s leading health sector professionals who are passionate about diversity and inclusion
Rush University Medical Center
Allecia has 20+ years of experience in clinical research working for pharmaceutical companies, contract research organizations, a consulting firm, and an academic medical center. She is currently the Associate Vice President of Clinical Research Administration in the Office of Research Affairs at Rush University and is Certified Clinical Research Professional (CCRP). At Rush University Medical Center, Allecia is responsible for the following:
Prior to joining Rush, Allecia was a Director at Huron Consulting Group, where she:
She is a member of the following organizations:
Allecia received her Bachelor of Science in Biology with a Minor in Biochemistry from Spelman College in Atlanta and a Master of Public Health in Epidemiology with a minor in Biostatistics from the University of Michigan in Ann Arbor.
She is a frequent presenter at national conferences and lives in Chicago with her husband, pre-teen son, and boxer puppy named Cassius Clay.
Healthcare Businesswomen’s Association
Ms. Laurie Cooke, RPh, is the CEO of the Healthcare Businesswomen’s Association. Leading the global organization with an impressive cadre of industry leaders, Laurie has created a united force for change as the HBA has a community size of 25,000 women and men, 120 corporate partners, and 24 chapters across the US and Europe. Prior to the HBA, Laurie served on the PMI executive management team responsible for the strategic product portfolio as her entry point into nonprofit leadership. Prior to this she held global leadership roles in the pharmaceutical industry serving on international teams driving shorter cycle times, global simultaneous submission, and effective corporate merger outcomes. Laurie is a dedicated advocate for gender parity making meaning change as a speaker and thought leader, and a proud award recipient with accolades such as the PharmaVOICE 100 most inspiring people in life sciences and ASAE Mentor of the Year. Laurie’s academic history includes a degree in Microbiology from the U of MD, an advanced scientific degree in Pharmacy from the U of WA, a master’s degree in Software Engineering Management from the U of Luton, England and she is a licensed Pharmacist and Certified Association Executive.
Mr. Everett Tucker is the Division Vice President, Global Operations Strategy and Engineering at Abbott. Mr. Tucker is a transformational, C level executive who energizes global teams to achieve operational excellence, revolutionize the customer experience, and create a culture of execution in private equity, Fortune 50, & mid size company environments. Previously, Everett was the Vice President, Global Engineering & Operations at CAE Healthcare. He has deep and broad experience in Customer Service, Engineering, Global Supply Chain Design, Supply Chain Operations, Manufacturing Operations, & Project Management. Accomplished at enabling growth & diversification, profitability, and organizational efficiency.
Ms. Cristina Santos brings 16 years of pharmaceutical experience and is currently Head of Multicultural Marketing for the Sanofi U.S. Diabetes and Cardiovascular portfolio, establishing this critical capability for the organization. The aim of her team is the “thoughtful and intentional inclusion of diverse patients and the customers that care for them in all aspects of the business”. In the past she’s been a leader of Diversity & Inclusion and several ERGs, continuing to fuel that passion today as a member of Sanofi’s D&I steering committee. During her tenure she’s held several commercial roles in Global Oncology, U.S. Sales Leadership, and Training & Development to name a few. A proud wife and mother of four, she was recognized in 2012 as a “Working Mother of the Year” in Working Mother Magazine.
Dr. Thomas Summerfelt, PhD, is the President, North America at Convergence CT. Prior to this role, Dr. Summerfelt is the Vice President of Research & Innovation at Advocate Health Care. Dr. Summerfelt earned his PhD from Vanderbilt University and focused his doctoral and post-doctoral training on Health Services Research. He has held faculty appointments at Vanderbilt, Michigan State, and University of Chicago. His scholarly work focuses on effectiveness research, program evaluation, and value-based analysis. At Advocate Health Care, he has used his university experiences to craft innovative approaches to research administration and support to investigators while focused on patient outcomes, compliance, efficiency, and effectiveness.
Dr. Ayesha Sitlani, PhD, is Executive Director, Biologics & Vaccines Bioanalytics at Merck. Ayesha Sitlani has had 18 years of experience at Merck leading vaccine and drug discovery and development, and published over 40 peer-reviewed publications and patents. Following the Merck-Schering merger in 2009, she led and executed several strategic, financial, and operational change initiatives to build, re-structure, and integrate Biologics, a new therapeutic modality, into Merck. Ayesha has had extensive experience in both line- and matrix-management and is passionate about developing talent and high-performing teams through stretch opportunities, cross-training and education. She received her B.A. from Smith College, M.A from Columbia University and her Ph.D in Biochemistry from the California Institute of Technology. She did a postdoctoral fellowship in Biophysical chemistry at Yale University prior to joining Merck in 1998.
Ms. Tamara Lazier Oyejide, MBA, is Associate Director, Patient Recruitment at PAREXEL, where she provides strategic leadership and outreach support across PAREXEL’s network of global clinical units. Tamara has almost 20 years of professional experience executing outreach campaigns across various industries (pharmaceutical, telecommunications and social media) and a broad background in clinical trials management of phase II/III trials in various indications. Her specialties include patient recruitment and retention strategy, marketing campaign creation and execution, brand management, media and vendor negotiations. Tamara earned her MBA in Marketing and BBA in Finance from Georgia State University – J. Mack Robinson College of Business.
Ms. Rachel Cheeks-Givan, MBA, is Global Director Diversity and Inclusion at Pfizer. She is also an Adjunct Professor at New York University, where she facilitated the delivery of Managing Diversity & Cultural Inclusion Masters Course in the School of Professional Studies HR Program. Ms. Cheeks-Givan is a Global Corporate Diversity and Inclusion Leader known for strategic planning and execution of cultural transformation in areas of employee and leadership engagement, learning and development and the advancement of women. Prior to join Pfizer, she was Director Global Diversity & Inclusion at PepsiCo. Ms. Cheeks-Givan earned her MBA from Southern Methodist University – Cox School of Business and her BBA in Accounting from Baruch College.
American Medical Association
Mr. Rodrigo A. Sierra , MBA, is is chief communications and marketing officer and senior vice president of the American Medical Association (AMA). There, he is leading a transformation of the 165-year-old organization to reclaim a leadership position in shaping the evolving healthcare system for the nation. The brand repositioning, media and public affairs expert is responsible at the AMA for public relations, enterprise marketing & communications, digital & social media, leadership positioning and brand strategy. Over a distinctive and award-winning career, Sierra has been instrumental in achieving meaningful results in high-profile corporate, media, government and regulatory positions. He has led change for Johnson Publishing Company, Integrys Energy Group, Peoples Energy, Mayor Richard M. Daley and the City of Chicago, WGN Radio, ABC News, and others. Rodrigo earned an MBA from the Kellogg School of Management and holds a bachelor’s degree in philosophy from Northwestern University. He and his wife, Elizabeth, live in Chicago where they are raising four sons.
Dr. Knikki Childs Pendleton, PharmD, is the Director for the Southeast Diabetes Regional Medical Liaison team at Sanofi. Dr. Pendleton completed her pre-pharmacy work at Emory University and then earned a Doctor of Pharmacy degree from Howard University in 1994. Knikki started her pharmaceutical career as a medical liaison at Gilead Sciences in 1999. She then joined Sanofi as a Regional Therapeutic Liaison and was promoted to Regional Director of the CV-RML team in 2005. In 2012, Dr. Pendleton was named “Field Medical Director of the Year” by her peers and the leadership at Sanofi. She was also selected as” Sanofi Talent Champion” for excellence in Leadership and mentorship in 2013. Dr. Pendleton holds memberships in the National Pharmaceutical Association and American Diabetes Association. She is also the Co- Lead of ADVANCE a diversity employee resource group at Sanofi.
Robert H. Lurie Comprehensive Cancer Center
Dr. Maha H. Hussain, MD, is the Senior Deputy Director & Associate Director for Clinical Sciences Research at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. She is also the Genevieve E. Teuton Professor of Medicine, and Professor of Medicine in the Division of Hematology/Oncology at the Feinberg School of Medicine.
As Associate Director for Clinical Research, Dr. Hussain is responsible for the development and oversight of clinical research in the Lurie Cancer Center, including the coordination of all cancer-related clinical research services throughout the Lurie Cancer Center and Northwestern Medicine. She chairs the Governance Committee of the Clinical Research Office, and serves on the Clinical Cancer Center Executive Council and the Lurie Cancer Center Executive Committee. Dr. Hussain also provides leadership for clinical faculty recruitment and oversees the Translational Research in Solid Tumors (TRIST) and Hematological Malignancies Programs in the Lurie Cancer Center.
Dr. Hussain’s research efforts are focused on the development of novel therapeutics integrating scientific advances into clinical trials for prostate and bladder cancer. Prior to join Robert H. Lurie Comprehensive Cancer Center, she was Cis-Maisel Professor of Oncology, and Professor of Medicine and Urology at the University of Michigan. Dr. Hussain’s extensive national scientific leadership roles include serving as Co-Chair of the Prostate Cancer Subcommittee/Genitourinary Cancer Committee of SWOG, where she guided research in areas of advanced prostate cancer that led to changing standards of care. She has served as a member and chair of the Integration Panel of the U.S. Army Medical Research and Materiel Command Prostate Cancer Research Program, and as a member and Chair of the U.S. Food and Drug Administration Oncology Drug Advisory Committee.
Biomedical Innovation Advisors
Dr. Susan Windham-Bannister is a nationally and internationally recognized innovation expert. She was recognized by the Boston Globe as one of the “10 Most Influential Women in Biotech” in 2013 and by Boston Magazine as one of the “50 Most Powerful Women in Boston” in 2011. Dr. Windham-Bannister currently serves as Managing Partner of Biomedical Innovation Advisors LLC, which she founded with Dr. Harvey Lodish, co-founder of Genzyme, and member of the Whitehead Institute, MIT. She also serves as the President and CEO of Biomedical Growth Strategies, LLC. Both of these advisory firms leverage Dr. Windham-Bannister’s experience as the immediate past President and CEO of the Massachusetts Life Sciences Center (MLSC), a state-funded investment organization charged with administering the $1-billion Life Sciences fund that was proposed by Governor Deval Patrick in 2007 and signed into law in June 2008. She is the first African American in the U.S. to lead a life sciences-focused innovation initiative of this scale. The MLSC is the hub for all sectors of the Commonwealth’s life sciences community – biotechnology, pharmaceuticals, medical devices, medical diagnostics and bioinformatics.
Dr. Windham-Bannister received a B.A. from Wellesley College, a Doctorate in Health Policy and Management from the Florence Heller School at Brandeis University, and a Doctor of Science from Worcester Polytechnic Institute (honoris causa). She completed her doctoral work at the Heller School under a fellowship from the Ford Foundation and was also a post-doctoral fellow at Harvard University’s John F. Kennedy School. Dr. Windham-Bannister also served as a Fellow in the Center for Science and Policy (CSAP) at Cambridge University, Cambridge, England.
United Negro College Fund
Dr. Chad Womack, PhD, is the National Director of STEM Initiatives at the United Negro College Fund, including the UNCF-Merck Fellowship Program and the co-founder and co-lead of the White House-supported HBCU Innovation, Commercialization & Entrepreneurship. He co-founded The America21 Project and DC Innovates, both innovation-based community and economic development nonprofit organizations dedicated to empowering metro-centers and underserved communities through STEM education, tech-entrepreneurship and access to capital. Dr. Womack also founded the Philadelphia Biotechnology & Life Sciences Institute as a nonprofit initiative dedicated to addressing unmet educational and workforce development needs of Philadelphia. He co-founded 3GEN Vaccines, a nano-biotechnology company. Prior to his entrepreneurial ventures, he completed research fellowships at the NIH, most recently at the National Institutes for Allergy and Infectious Diseases (NIAID) Vaccine Research Center (VRC) and at the Harvard AIDS Institute at the Harvard School of Public Health and the Department of Immunology and Infectious Diseases.
Dr. Charlotte Jones-Burton, MD, MS, is the Global Clinical Research Program Lead at Bristol-Myers Squibb. Dr. Charlotte Jones-Burton is an entrepreneurial leader who has brought innovation and passion to her diverse roles within the healthcare industry over the last 20+ years as biopharmaceutical medical director, thought leader in clinical trial research, internal medicine and nephrology physician, and professor. In her role at Bristol-Myers Squibb, Dr. Jones-Burton leads cross-functional teams to design, implement, and oversee clinical trial studies for innovative medicines. She has also achieved a high level of success as an entrepreneur in direct sales and franchise industries. Her education includes a MD and a MS in Epidemiology and Preventive Medicine from University of Maryland School of Medicine.
Mr. David Cousins, MS, is a Managing Director at Abbott. Previously, he was a Vice President Commercial of the Great Lakes Region at Quest Diagnostics since 2012. Prior to that role, he was a Director of Sales at Quest Diagnostics since 2011. His former positions include Managing Director at Novartis and a Director of Marketing and Sales at Novartis Transplant & Infectious Disease. Mr. Cousins received his BA in Economics from Duke University and his MS in Organizational Dynamics from the University of Pennsylvania. David is a veteran of the U.S. Air Force. His specialties include account management, project management, budgeting, forecasting, sales, and strategy.
Dr. Bonnie Lai, PhD, is Vice President of Pharmacy Solutions at Procured Health, a technology company forefront of helping health systems achieve the best clinical outcomes at an optimal cost. Prior to Procured Health, Dr. Lai worked for five years at The Boston Consulting Group (BCG), a management consulting firm where she served clients across the healthcare industry (pharmaceuticals, medical devices, payers, providers). Dr. Lai was a member of BCG’s Career Development Committee responsible for performance evaluation and a recipient of the Journeyman Award for people development. Dr. Lai holds a bachelor’s from Northwestern University and PhD from Duke University in biomedical engineering.
Ms. Lori Tierney, MBA, is Vice President, US Commercial Operations at AstraZeneca. Lori has more than 20 years of experience in sales and marketing leadership positions, domestically and globally across a wide range of organizations, including biopharmaceuticals, medical device and diagnostics and health information technology. Before joining AstraZeneca, Lori was at Endo Pharmaceuticals where she held the roles of VP of Commercial Operations and Senior Vice President, Commercial Innovation and Customer Solutions during her tenure. Before that, she held several senior positions across sales, marketing and operations at Centocor/Johnson & Johnson. Lori was the 2011 recipient of the Rising Star Award by Healthcare Businesswoman’s Association. Her education background includes an MBA from Villanova University and a Bachelor’s degree from Drexel University.
Rush University Medical Center
Dr. Neelum Aggarwal, MD, is is a neurologist in the Departments of Neurological Sciences and the Rush Alzheimer’s Disease Center and Director for Research at the Rush Heart Center for Women at Rush University Medical Center in Chicago, IL. She is a clinical researcher, and specializes in Alzheimer’s Disease dementia and Vascular dementia and is the Site Principal Investigator for multiple NIH funded clinical trials in the areas of healthy aging and dementia of Alzheimer’s Disease.(https://www.rush.edu/services/alzheimers-disease-center/clinical-trials).
She is the co-principal investigator for the Community Engagement for Early Recognition and Immediate Action in Stroke (CEERIAS) study, which addresses disparities in stroke awareness, barriers to health care access, and treatments and outcomes in Chicago’s minority communities. As AMWA’s Chief Diversity Officer for the American Medical Women’s Association, she is responsible for enhancing the diversity of AMWA’s leadership team, and leading AMWA’s Diversity and Inclusion Section and resource groups. She has authored multiple peer reviewed manuscripts and book chapters, presented at national and international conferences on topics of aging and dementia and serves on national and international Advisory boards commenting on findings from aging research in the areas of women’s brain health, racial and ethnic minorities and special populations.
Dr. Paul Underwood, MD, FACC, FSCAI is a medical director for the interventional cardiology/structural heart franchise at Boston Scientific and a member of Close the Gap, Boston Scientific’s health equity education initiative. At Boston Scientific, Dr. Underwood recently received the Interventional Cardiology Business Unit Diversity Award for his work with the PLATINUM Diversity trial, the first interventional cardiology study to focus solely on women and minorities. In 2015 he also received the Chairperson’s Award from the National Forum for Heart Disease and Stroke Prevention. Prior to Boston Scientific, Dr. Underwood practiced interventional cardiology and clinical research in Phoenix for over 18 years and has been actively involved in community-based efforts focused on promoting cardiovascular health. He received his MD degree from the Mayo Clinic, followed by a cardiology fellowship at the Cleveland Clinic.
Dr. Khaudeja Bano, MD, is a Physician with a Masters in Clinical Research (UCSD), Pharmaceutical engineering Certification, an Oracle DBA, and a certified Project Management Professional. She is an Abbott President’s award winner, avid Toastmaster and certified coach. Khaudeja has more than 25 years professional experience, including clinical practice. She has held several global safety positions at Guidant, Abbott Vascular, Abbott Diagnostics, Abbott Established Pharma Division, and AbbVie Inc. Her career includes global medical / clinical and safety leadership roles in devices, diagnostics, pharmaceuticals and combination products.
Ms. Almenia Garvey, MS, is Director, Health Care Alliances at ICON Plc. With over 20 years of clinical research experience, she is a strong leader and proven relationship builder. Almenia is a site relations expert who specializes in minority recruitment, site selection strategy, investigator identification and investigator relationship management. ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. Her prior role was Associate Director, Site Alliances at PAREXEL. Her education includes a M.Sc., Communication, Advertisement and Public Relations from Ulster University.
Bridge Clinical Research
Dr. Owen Garrick, MD, MBA, is President & COO of Bridge Clinical Research. Bridge Clinical is a global patient recruitment healthcare communications company. It is also the leading company focused on increasing the participation of minority investigators and patients in clinical trials. Dr. Garrick was formerly Director of Corporate Strategy and M&A at McKesson. Prior to McKesson, Dr. Garrick was Global Head of M&A Negotiations at Novartis. Previously he was at Goldman Sachs in New York. Dr. Garrick earned his MD from Yale, MBA from Wharton. He holds an AB from Princeton University. Dr. Garrick also serves on the boards of Sutter Health, the American Psychiatric Association Foundation and Samuel Merritt University. He was confirmed to the HHS Secretary’s Advisory Committee on Human Research Protections in 2012.
University of Chicago Medical Center
Ms. Brenda Battle, MBA, BSN, RN, serves as The University of Chicago Medical Center’s Vice President for Care Delivery Innovation and Chief Diversity and Inclusion Officer. She is responsible for leading UCMC’s transformation to population health management, implementing new models of care and integrating care between the hospital and community. Battle’s prior experience includes serving as the director of the Center for Diversity and Cultural Competence for Barnes-Jewish Hospital on the Washington University Medical Center Campus, St. Louis, MO. She served as a health care lobbyist for several years and held several leadership roles in the managed care industry.
The Kaleidoscope Group
Mr. Doug Harris is the Chief Executive Officer of The Kaleidoscope Group with almost 30 years of experience in the field of diversity & inclusion consulting. Prior to joining Bea Young Associates in 1993, Doug worked for several years as a consultant and trainer for Harbridge House, Inc. where he facilitated diversity & inclusion education sessions with senior executives of Fortune 500 organizations. Today, as the leader of The Kaleidoscope Group, Doug empowers organizations to achieve their diversity and inclusion goals. His knowledge and expertise guides organizations through the creation of customized strategies that address the specific diversity needs of the business. He recently developed and launched The Kaleidoscope Group Youth Practice to assist underserved youth in the Chicagoland and surrounding communities and is working with Tufts University to design and implement a student leadership development program.
Ms. Leslie M. Stokes, MBA, was the Senior Vice President of Physician Engagement at the American Medical Association. She is the executive sponsor of a Diversity Initiative that launched in 2015. Prior to AMA, Leslie spent more than 20 years of combined sales and marketing experiences at Merck, Johnson & Johnson and Baxter Healthcare. During her time at Baxter, she worked in Global Marketing and was also the Co-President of the African-American Leadership Council, a newly formed business resource group. Leslie holds a BS in Business Administration and Marketing from Penn State University and an MBA in International Business from Temple University. Leslie lives in downtown Chicago and in her spare time enjoys mentoring early career professionals.
Ms. Dima Elissa, MBA, is the CEO and founder of VisMed-3D, a medical 3D printing company. She is also the Diversity, Inclusion, and Innovation (D & I2) – Tech & Innovation Lead at American Medical Women’s Association. As an adjunct faculty member teaching Entrepreneurship at the Associated Colleges of the Midwest in Chicago and in-demand speaker, she exemplifies her commitment to giving back and paying it forward. She currently serves on the boards of mHUB Chicago, BWG Strategy LLC, Ms. Tech, Women in Bio, Galvanize Labs, and is on the STEM steering committee for the Aparecio Foundation, which provides mentoring to high-achieving, low- income female high school students. Dima holds a B.A. in Chemistry from Hanover College, and earned her MBA from Texas A&M’s May’s School of Business with a concentration in Finance.
Healthcare Research Associates
Ms. Regina Greer-Smith, MPH, is a member of the Advisory Panel for Patient Engagement at the Patient Centered Outcomes Research Institute (PCORI). Regina is the President and Owner of Healthcare Research Associates, LLC. Regina’s work includes building and maintaining collaborations between communities and stakeholders that enable improved healthcare outcomes. Regina is a consultant /healthcare coordinator to agencies providing services to developmentally and intellectually disabled adults in Illinois and the use of mobile technology to enable collaboration between patients/caregivers and providers. She is the developer and principal investigator of The S.T.A.R. Initiative. The mission of The S.T.A.R. Initiative is to increase minority participation in patient-centered outcomes research and clinical trials. Regina holds a Master of Public Health Degree (MPH) from Benedictine University and is a Fellow with The American College of Healthcare Executives.
by Doug Harris11:15 AM
191 N. Wacker Drive | Suite 3700
Chicago, IL, USA 60606
Please contact us with any symposium questions.